Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 26, 2026
TickeronGET DAILY SIGNALS
Universal Health Realty Income Trust (UHT) Q3 2026 Earnings Preview

Universal Health Realty Income Trust (UHT) Q3 2026 Earnings Preview

Key Takeaways

  • Universal Health Realty Income Trust (UHT), a healthcare-focused real estate investment trust (REIT), is expected to report third-quarter 2026 results after the market close on October 26, 2026.
  • Wall Street anticipates revenue of roughly $24.9 million to $25 million, broadly in line with the trust's recent quarterly run rate.
  • Investors will focus on funds from operations (FFO), a key profitability measure for REITs, which reached $0.90 per share in the second quarter of 2026.
  • The $0.75 quarterly dividend, which translates to a yield of about 8%, and its coverage ratio remain the central watch items heading into the report.
  • Tenant concentration with Universal Health Services and the pressure from higher interest rates are the primary risk factors to monitor.
  • For more detail on UHT's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages for this ticker.
  • Looking for new trade ideas? Explore Trending AI Robots for AI-driven market signals.

The Business Behind UHT and Why the Report Matters

Universal Health Realty Income Trust owns and leases healthcare and human-service properties across roughly 20 U.S. states, with about two-thirds of its asset value concentrated in medical office buildings and the remainder in acute care and behavioral health hospitals, freestanding emergency departments, and childcare centers. Because the trust earns recurring revenue from long-term leases with contractual rent escalators, its quarterly results are closely watched as a barometer of the healthcare real estate market. The upcoming report matters to income-focused investors because the trust's elevated dividend yield and tenant concentration with Universal Health Services leave it sensitive to both operating stability and borrowing costs. I also checked this using Tickeron’s AI Screener to see how UHT stacks up against other healthcare REITs.

Earnings Expectations

Analysts expect Universal Health Realty Income Trust to report third-quarter 2026 revenue of approximately $24.9 million to $25 million, a figure consistent with the $24.99 million reported in the second quarter of 2026 and the roughly $24.5 million recorded in the first quarter. On the earnings front, investors will look beyond the headline figure to FFO per share, which stood at $0.90 in the second quarter, up about 6.1% year over year, according to earnings-related commentary. The trust's GAAP (Generally Accepted Accounting Principles) earnings per share have been more volatile, ranging from $0.31 to $0.43 across recent quarters, reflecting non-cash items common to REITs. Beyond the top and bottom lines, key metrics include occupancy and leasing trends in the medical office portfolio, rent escalations, and the dividend coverage ratio. From what I see in the data, these details will help clarify the sustainability of the payout.

Market Reaction and Investor Sentiment

Sentiment heading into the third-quarter report has been cautious. UHT shares have pulled back from their 52-week high, pressured by rising Treasury yields and elevated interest rates, which weigh on rate-sensitive REITs through higher borrowing costs and compressed valuations. Google Finance data indicates the stock has traded in a range of roughly $35 to $46 over the past year, with the share price sitting near the lower portion of that band. Analysts have pointed to a high payout ratio as a source of concern for dividend sustainability, while recent institutional selling has added to the cautious tone. Against this backdrop, the market is likely to react to any signal that FFO and cash flow remain sufficient to support the $0.75 quarterly distribution.

Forward Outlook and Key Factors to Monitor

Following the third-quarter report, investors should watch several factors that will shape the trust's trajectory. First is dividend coverage: with a payout ratio that has run well above 100% of GAAP earnings, the relationship between FFO and the quarterly distribution will be scrutinized for any sign of strain.

Second is tenant concentration. Universal Health Services serves as the trust's advisor, its largest tenant, and the guarantor of leases on several hospital properties, representing roughly 40% of revenue. Any commentary on that tenant relationship or on lease renewals will carry outsized weight.

Third is the interest-rate environment. As a capital-intensive REIT, the trust's cost of debt refinancing and its ability to fund future acquisitions depend on where borrowing costs settle. Rising Treasury yields have already pressured the sector, and any change in the rate outlook could influence both valuation and growth plans.

Finally, investors should monitor occupancy and leasing activity across the medical office portfolio, as well as any updates on properties under construction. These operating details will help clarify whether the trust can sustain modest growth in FFO while preserving its high-yield distribution in a more expensive financing climate. I’m watching this closely with the help of Tickeron’s AI Trend Prediction Engine for any shifts in the broader REIT landscape.

Using Tickeron’s AI Tools in My Research

In preparing for earnings like this one from UHT, I frequently rely on Tickeron’s AI Screener to quickly filter healthcare REITs by fundamentals, technical patterns, and AI signals. It helps me compare dividend coverage, occupancy trends, and sector peers without spending hours on manual searches, giving a clearer picture of where risks and opportunities may lie. This kind of tool has become a regular part of my workflow for staying on top of income-focused names.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: UHT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


UHT's RSI Oscillator ascends from oversold territory

The RSI Indicator for UHT moved out of oversold territory on October 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 32 similar instances when the indicator left oversold territory. In 25 of the 32 cases the stock moved higher. This puts the odds of a move higher at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 31 of 55 cases where UHT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 56%.

The Moving Average Convergence Divergence (MACD) for UHT just turned positive on October 09, 2026. Looking at past instances where UHT's MACD turned positive, the stock continued to rise in 29 of 51 cases over the following month. The odds of a continued upward trend are 57%.

Following a +0.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where UHT advanced for three days, in 173 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.

UHT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UHT as a result. In 46 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.

The 50-day moving average for UHT moved below the 200-day moving average on October 07, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where UHT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

The Aroon Indicator for UHT entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 44 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. UHT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.642) is normal, around the industry mean (3.123). P/E Ratio (27.129) is within average values for comparable stocks, (28.374). Projected Growth (PEG Ratio) (2.840) is also within normal values, averaging (1.649). Dividend Yield (0.080) settles around the average of (0.048) among similar stocks. P/S Ratio (5.705) is also within normal values, averaging (6.013).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UHT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 62, placing this stock worse than average.

Industry description

The industry includes companies that publish and market books and magazines/periodicals. John Wiley & Sons, Inc., Meredith Corporation and Scholastic Corporation are some of the biggest companies in this industry. Like many other industries, publishing companies have branched out into online/digital publications (while retaining their original print business), to capture the burgeoning market in electronic media. Business could be cyclical in certain cases, since weak consumer sentiment during an economic downturn might depress sales of some magazines and books.

Market Cap

The average market capitalization across the Publishing: Books/Magazines Industry is 16.82B. The market cap for tickers in the group ranges from 113.09K to 173.38B. WELL holds the highest valuation in this group at 173.38B. The lowest valued company is DIGI at 113.09K.

High and low price notable news

The average weekly price growth across all stocks in the Publishing: Books/Magazines Industry was 3%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 2%. DHC experienced the highest price growth at 6%, while MPT experienced the biggest fall at -2%.

Volume

The average weekly volume growth across all stocks in the Publishing: Books/Magazines Industry was -28%. For the same stocks of the Industry, the average monthly volume growth was 17% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 66
P/E Growth Rating: 55
Price Growth Rating: 55
SMR Rating: 77
Profit Risk Rating: 61
Seasonality Score: 46 (-100 ... +100)
View a ticker or compare two or three
UHT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry PublishingBooksMagazines

Industry
Real Estate Investment Trusts
Address
367 South Gulph Road
Phone
+1 610 265-0688
Employees
5
Web
https://www.uhrit.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
TSMX, a 2x daily leveraged single-stock ETF (exchange-traded fund), rose roughly +19% over the trailing 30 days, rebounding sharply from mid-September lows. The fund seeks 200% of the daily return of TSM (Taiwan Semiconductor Manufacturing), meaning its moves are roughly double the underlying stock's daily swings.
Contracted revenue anchor: A roughly $3.2 billion, seven-year LNG (liquefied natural gas) supply agreement with Puerto Rico has received final approval, providing multi-year cash-flow visibility if execution stays on track. Project pipeline inflection: Upcoming milestones include the Barcarena and PortoCem power plants in Brazil, a potential Gás Sul terminal restart, and optimization of the company's modular "Fast LNG" (FLNG) liquefaction fleet.
AMD (Advanced Micro Devices) designs central processing units (CPUs), graphics processing units (GPUs), and AI accelerators, while LRCX (Lam Research) supplies the wafer-fabrication equipment used to build advanced chips. AMD has delivered strong double-digit revenue growth on AI data-center demand, but its shares trade with elevated expectations that can trigger sharp reactions around earnings.
Origination momentum: Velocity Financial enters 2026 off record annual originations of roughly $2.7 billion (up about 48%), positioning it to keep gaining share in a fragmented investor-loan market. Credit normalization is the central watch item: Nonperforming loans fell toward the 8.5% range of portfolio unpaid principal balance (UPB), but asset quality remains the primary swing factor for earnings.
Turnaround milestone ahead: Management has pointed to reaching cash generation in 2027, making the pace of cost discipline and margin recovery the central question for the stock forecast. Fresh capital supports execution: A recently announced $45.5 million equity financing, with participation from management and a single institutional investor, strengthens the balance sheet as the company funds its transformation.
NFE closed at $5.51, down -6.13% during Tuesday's regular session, extending a slide that has pushed shares near a 52-week low. Primary catalyst: the company disclosed its Fast LNG unit is offline after a gas-turbine mechanical failure, with return to service not expected until Q4.
The central $11 target is the arithmetic mean of four verified analyst price targets, rounded from roughly $10.75. With the stock near $2.06, reaching $11 would require an upside of more than 400%, an extremely large move.
The $23 central target is the rounded arithmetic mean of four verified analyst price targets, which average $23.25. The latest verified price is around $9.57, meaning the target implies roughly 140% upside—a very large move.
NXH closed down -11.17% (-$0.23) to $1.83 on Oct 6, the most recent regular session, extending a steep two-day decline. Selling continued as investors digested the mutual termination of the Fathom Holdings merger and a dilutive $45.5M registered direct offering of ~16.5M shares at $2.76.
AMD is a large-cap designer of CPUs (central processing units) and GPUs (graphics processing units) competing directly with Nvidia in the AI accelerator market, while FORM is a small-cap provider of semiconductor test and measurement equipment, primarily probe cards. AMD's narrative has been driven by multi-billion-dollar hyperscaler deals, while FORM's has been powered by record revenue and sharp margin expansion tied to high-bandwidth memory (HBM) demand.
AMD has surged roughly 200% year to date, crossing a $1 trillion market capitalization on AI data-center demand and a "CPU renaissance" narrative. KLAC has gained about 71% year to date, supported by record process-control revenue and rapid growth in advanced packaging for AI chips.
AMD is a large-cap semiconductor designer riding explosive AI compute demand, while ENTG is a mid-cap supplier of materials and purity solutions that feed the same AI-driven chip cycle. AMD recently crossed a $1 trillion market capitalization on surging data center revenue, whereas ENTG operates at a far smaller scale (roughly $23 billion) with steadier, double-digit growth.
VELO closed Tuesday at $9.57, unchanged (+0.00%) from the prior session, with the move occurring during regular market hours. The flat close marked stabilization after Monday's -14.5% plunge, when shares fell to $9.57 from $11.20 following disclosure of CFO James Suva's departure.
The $8 target used here is a technical, publicly discussed recovery objective — not an analyst consensus — because legacy analyst price targets were set before NFE's restructuring and reverse stock split. New Fortress Energy Inc. ( NFE ) trades near $5.51, so reaching $8 implies a roughly 45% advance.
AVBP plunged -46.98% during Tuesday's regular session, closing at $15.09 versus $28.46, marking its worst single-day decline on record. The catalyst was the Phase 3 FURVENT trial of firmonertinib failing its primary endpoint—progression-free survival—in first-line EGFR exon 20 insertion non-small cell lung cancer.
Upcoming catalyst: The company's next earnings release is estimated for November 6, 2026, which should offer fresh detail on its SKY token holdings, staking rewards, and treasury strategy. Strategic positioning: SDEV is an on-chain holding company providing public-market exposure to the Sky protocol ecosystem, with SKY as its core digital asset and a stated focus on the stablecoin economy.
Different roles in the chip ecosystem: AMAT is a materials-engineering and deposition leader, while KLAC dominates process control, inspection, and yield management. Momentum favors AMAT: AMAT shares have more than doubled this year, while KLAC has recently pulled back roughly 9% in a month on margin and execution concerns.